Scholars Central

Conference abstractPublished 31 Aug 2018

The forefront of Amazonia biodiversity studies: from neglected diseases to biotechnology

Authors: Valdir F Veiga

Military Institute of Engineering, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The announced and celebrated the biotechnological potential of the Amazon Region never came true other than short brief sighs of development in the Age of Rubber. With important issues of sovereignty involved, in the nine countries where the Amazonia occupies an extensive region of 5.5 million km2 with immense historical logistical challenges, the region's bioproducts are marketed as commodities. Heterogeneous, extractive products without technology have the low added value that makes the maintenance of standing forest unfeasible. Essential, fixed and resinous oils are some of the materials with greater possibilities of standardization and production on an industrial scale. Residual materials from the fruit pulp and fatty oil industries also contain substances of great interest, byproducts that can be extracted prior to the use of biomass in bio refinery application models. Studying the chemical composition of several oils and extracts and searching for intrinsic variations by region, biotic and abiotic factors, we relate their characteristics to biological actions, especially to neglected diseases, describe patterns of the composition by Amazonian mesoregion, define chemical fingerprints and finally achieved new scaleable products. With a systematic research on the phytochemistry of several of these historical potential products, we were able to define the parameters for the quality control that allow their use as drugs, in Protected Designation of Origin (AOC) systems, and the production of byproducts that improve the value chains and create bioproducts where there were only promises, poverty and environmental agroindustry problems.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Valdir F Veiga”